Form EFFECT Lumexa Imaging Holdings,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 10, 2025 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Starts Lumexa Imaging Holdings (LMRI) at Buy
- Triple Negative Breast Cancer Market to Witness Strong Growth and Significant Market Expansion by 2036 – DelveInsight | Akeso Biopharma, ProLynx, ModernaTX, OncoTherapy Science, Phoenix Molecular
- Age-Related Macular Degeneration Market Valued at USD 9,840 Million in 2021, Set for Further Growth Through 2034Age-Related Macular Degeneration Market
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
